AI English summary of an SEC filing — figures as filed
GE HealthCare GEHCThe company said fourth-quarter revenue was $5.2 billion, up 5% from a year earlier, with price and volume as the drivers. Net income margin was 7.7%, compared with 11.2% a year earlier, down 350 basis points. The company cited standalone interest expense as the factor.
Key points
AI summaryThe company said fourth-quarter revenue was $5.2 billion, up 5% from a year earlier, with price and volume as the drivers. Net income margin was 7.7%, compared with 11.2% a year earlier, down 350 basis points. The company cited standalone interest expense as the factor.
GE HealthCare said full-year revenue for 2023 was $19.6 billion, up 7% from the prior year and up 8% on an Organic basis. Adjusted EBIT margin was 15.1%, compared with 15.6% a year earlier, down 50 basis points, but was 60 basis points above the estimated 2022 Standalone Adjusted EBIT margin of 14.5%.
The company said cash flow from operating activities for 2023 was $2.1 billion and free cash flow was $1.7 billion, down $113 million from the prior year, citing standalone interest and postretirement benefit payments. It repaid $850 million of debt in Q4 2023 and an additional $150 million in January 2024.
The company provided full-year 2024 guidance of Organic revenue growth of approximately 4%, Adjusted EBIT margin of 15.6% to 15.9%, Adjusted EPS of $4.20 to $4.35, and free cash flow of approximately $1.8 billion. The company said the Adjusted EPS range represents growth of 7% to 11% versus Adjusted EPS of $3.93 for 2023.
Summary
AI-writtenAnalysis scope · Filing body and confirmed press-release exhibitWe analyzed the opening part of the filing body and confirmed exhibits, within a length limit. This is not a review of other exhibits, investor presentations or the full earnings call.
GE HealthCare Q4 2023 Revenue $5.2 billion and Net Income Margin
The company said fourth-quarter revenue was $5.2 billion, up 5% from a year earlier, with price and volume as the drivers. Net income margin was 7.7%, compared with 11.2% a year earlier, down 350 basis points. The company cited standalone interest expense as the factor.
Source · Based on the filing body and exhibits
2023 Full-Year Revenue and Adjusted EBIT Margin
GE HealthCare said full-year revenue for 2023 was $19.6 billion, up 7% from the prior year and up 8% on an Organic basis. Adjusted EBIT margin was 15.1%, compared with 15.6% a year earlier, down 50 basis points, but was 60 basis points above the estimated 2022 Standalone Adjusted EBIT margin of 14.5%.
Source · Based on the filing body and exhibits
2023 Full-Year Operating Cash Flow, Free Cash Flow and Debt Repayment
The company said cash flow from operating activities for 2023 was $2.1 billion and free cash flow was $1.7 billion, down $113 million from the prior year, citing standalone interest and postretirement benefit payments. It repaid $850 million of debt in Q4 2023 and an additional $150 million in January 2024.
Source · Based on the filing body and exhibits
2024 Full-Year Guidance
The company provided full-year 2024 guidance of Organic revenue growth of approximately 4%, Adjusted EBIT margin of 15.6% to 15.9%, Adjusted EPS of $4.20 to $4.35, and free cash flow of approximately $1.8 billion. The company said the Adjusted EPS range represents growth of 7% to 11% versus Adjusted EPS of $3.93 for 2023.
Source · Based on the filing body and exhibits
AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.
Original filing
The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.
Loading the filing text…